Molbio Diagnostics Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q1 FY27 earnings call
Molbio Diagnostics reported consolidated Q1 FY27 revenue from operations of ₹408 crores, EBITDA of ₹104 crores at a 25% margin, and profit after tax of ₹52.7 crores. Management said the company sold 164 devices and 62.4 lakh kits during the quarter, with export revenue of around ₹67 crores including a catch-up of deferrals from Q4 FY26 due to the situation in the Gulf. Management also discussed R&D investment, capacity utilization, the OptraScan and Prognosys subsidiaries, and provided full-year revenue and EBITDA guidance for FY27.